Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight

JK Kim, BT Tierney, EG Overbey, E Dantas… - Nature …, 2024 - nature.com
Spaceflight induces an immune response in astronauts. To better characterize this effect, we
generated single-cell, multi-ome, cell-free RNA (cfRNA), biochemical, and hematology data …

Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflight

N Houerbi, JK Kim, EG Overbey, R Batra… - Nature …, 2024 - nature.com
As spaceflight becomes more common with commercial crews, blood-based measures of
crew health can guide both astronaut biomedicine and countermeasures. By profiling …

SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions

Q Deng, P Lakra, P Gou, H Yang, C Meydan, M Teater… - Cancer cell, 2024 - cell.com
SMARCA4 encodes one of two mutually exclusive ATPase subunits in the BRG/BRM
associated factor (BAF) complex that is recruited by transcription factors (TFs) to drive …

Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology

H Cope, J Elsborg, S Demharter, JT McDonald… - Communications …, 2024 - nature.com
Background Spaceflight poses a unique set of challenges to humans and the hostile
spaceflight environment can induce a wide range of increased health risks, including …

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

A Bolomsky, M Ceribelli, S Scheich, K Rinaldi… - Cancer Cell, 2024 - cell.com
Multiple myeloma (MM) is an incurable plasma cell malignancy that exploits transcriptional
networks driven by IRF4. We employ a multi-omics approach to discover IRF4 …

SWI/SNF regulation of germinal center fate and lymphomagenesis

Q Sievers, O Abdel-Wahab - Cancer Cell, 2024 - Elsevier
The mSWI/SNF subunits ARID1A and SMARCA4 are mutated in B cell lymphomas. Now,
Barisic et al. and Deng et al. find that loss of ARID1A or SMARCA4 contributes to …

Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

K Wenzl, ME Stokes, JP Novak, AM Bock, S Khan… - Blood Cancer …, 2024 - nature.com
Recent genetic and molecular classification of DLBCL has advanced our knowledge of
disease biology, yet were not designed to predict early events and guide anticipatory …

A bioinformatic pipeline for integration of low and high dimensional multiomic datasets

K Doshi - 2024 - open.library.ubc.ca
Follicular Lymphoma (FL) is an indolent type of Non-Hodgkin's Lymphoma comprising 20%
of new lymphoma diagnosis with a risk of transforming into a more aggressive B-cell …